RCC-KL Cells

The RCC-KL cell line is derived from renal cell carcinoma (RCC), a common type of kidney cancer that typically arises from the epithelial cells of the kidney’s proximal tubules. RCC-KL is utilized as an in vitro model to study the biological and pathological mechanisms underlying renal cell carcinoma. Researchers commonly employ RCC cell lines like RCC-KL to investigate cancer growth, invasion, and therapeutic responses in the context of kidney cancer. Although detailed genetic information on RCC-KL is limited, renal cell carcinoma models are often used to explore the roles of key pathways involved in cancer progression, including those related to hypoxia, angiogenesis, and immune evasion. As such, RCC-KL may be valuable for studying drug responses and testing novel therapeutic agents, which is critical for developing improved treatments for kidney cancer. Given the complexity of RCC, cell lines like RCC-KL are instrumental in preclinical research focused on understanding drug resistance mechanisms and the interactions between cancer cells and the immune system. However, further characterization and published research are needed to fully elucidate the specific features and applications of RCC-KL in scientific studies.